Advertisement
UK markets close in 2 hours 24 minutes

  • FTSE 100

    8,077.63
    +32.82 (+0.41%)
     

  • FTSE 250

    19,772.28
    -27.44 (-0.14%)
     

  • AIM

    755.00
    +0.13 (+0.02%)
     

  • GBP/EUR

    1.1640
    +0.0013 (+0.11%)
     

  • GBP/USD

    1.2443
    -0.0010 (-0.08%)
     

  • Bitcoin GBP

    53,175.76
    +9.27 (+0.02%)
     

  • CMC Crypto 200

    1,434.66
    +10.56 (+0.74%)
     

  • S&P 500

    5,070.55
    +59.95 (+1.20%)
     

  • DOW

    38,503.69
    +263.71 (+0.69%)
     

  • CRUDE OIL

    83.31
    -0.05 (-0.06%)
     

  • GOLD FUTURES

    2,335.50
    -6.60 (-0.28%)
     

  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     

  • HANG SENG

    17,201.27
    +372.34 (+2.21%)
     

  • DAX

    18,150.67
    +13.02 (+0.07%)
     

  • CAC 40

    8,135.88
    +30.10 (+0.37%)
     
Money:

The five essential pieces of financial paperwork you must never lose

Mislaying key documents can cause real headaches, so it’s worth tracking down these most commonly-lost bits of paperwork

Should You Buy Cannabis Stocks & ETFs Now?

Neena Mishra
·2-min read

  • (1:50) - What Sectors Of The Market Should Investor Be Keeping An Eye On?

  • (5:30) - The Recent Positive Run For The Cannabis Industry

  • (11:20) - What Is The Impact To The Industry With Changing State Laws

  • (17:35) - When Could Investors Expect A Federal Legalization?

  • (25:00) - What Sectors Of The Industry Are Showing The Most Growth?

  • (33:50) - Amplify Seymour Cannabis ETF: CNBS

  • (46:45) - Episode Roundup: Podcast@Zacks.com

 

In this episode of ETF Spotlight, I speak with Tim Seymour, CIO of Seymour Asset Management and co-host of CNBC's Fast Money, and Christian Magoon, CEO of Amplify ETFs. We discuss cannabis investing and the Amplify Seymour Cannabis ETF CNBS, which is actively managed by Tim.

Cannabis stocks & ETFs have done quite well over the past few weeks as a Biden administration is expected to support decriminalization of recreational marijuana and legalization of medicinal marijuana at the federal level.

ADVERTISEMENT

New Jersey, Arizona, Montana and South Dakota have voted to make recreational marijuana legal and Mississippi approved its medical use, starting next year. Medical use of marijuana is already legal in 33 states and in the District of Columbia, while its recreational use is legal in 11 states and DC.

Cannabis however remains illegal at the federal level. That results in major challenges for US marijuana companies.  Further, the industry is evolving rapidly and therefore these stocks are very volatile. What lies ahead?

GW Pharmaceuticals GWPH, Canopy Growth Corporation CGC, Cronos Group CRON, Innovative Industrial Properties IIPR, GrowGeneration GRWG and Aphria APHA are CNBS’s top holdings. What do investors need to know about these companies? We also discuss recent quarterly earnings of major cannabis companies.

Make sure to be on the lookout for the next edition of ETF Spotlight! If you have any comments or questions, please email podcast@zacks.com.

Want key ETF info delivered straight to your inbox?

Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
GW Pharmaceuticals PLC (GWPH) : Free Stock Analysis Report
 
Innovative Industrial Properties, Inc. (IIPR) : Free Stock Analysis Report
 
Canopy Growth Corporation (CGC) : Free Stock Analysis Report
 
Cronos Group Inc. (CRON) : Free Stock Analysis Report
 
Aphria Inc. (APHA) : Free Stock Analysis Report
 
GrowGeneration Corp. (GRWG) : Free Stock Analysis Report
 
Amplify Seymour Cannabis ETF (CNBS): ETF Research Reports
 
To read this article on Zacks.com click here.
 
Zacks Investment Research